GNRH1 and polycystic ovary syndrome: Given the substantial evidence for improved safety and equal efficacy, current international evidence-based guidelines recommend the use of GnRH antagonist protocols as the preferred approach to controlled ovarian stimulation for patients with PCOS (45, 46).